BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BCRX BioCryst制药

盘前交易 07-24 04:25:46 EDT

7.47

+0.05

+0.67%

最高7.61	最低7.29	成交量235.98万
今开7.36	昨收7.42	日振幅4.31%
总市值15.42亿	流通市值14.28亿	总股本2.06亿
成交额1,768万	换手率1.23%	流通股本1.91亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BCRX","market":"US","secType":"STK","nameCN":"BioCryst制药","latestPrice":7.47,"timestamp":1721764800000,"preClose":7.42,"halted":0,"volume":2359792,"delay":0,"floatShares":191221848,"shares":206377088,"eps":-1.062062,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.05,"latestTime":"07-24 04:25:46 EDT","open":7.36,"high":7.61,"low":7.29,"amount":17678440.054862402,"amplitude":0.043127,"askPrice":8.3,"askSize":100,"bidPrice":5.67,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.062062,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721827800000},"adr":0,"listingDate":762670800000,"adjPreClose":7.47,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":7.47,"preClose":7.47,"latestTime":"19:33 EDT","volume":110932,"amount":829207.3953,"timestamp":1721777586895},"volumeRatio":0.8478010818402243,"impliedVol":0.5977,"impliedVolPercentile":0.2271},"requestUrl":"/m/hq/s/BCRX","defaultTab":"news","newsList":[{"id":"2452949290","title":"BioCryst制药盘中异动 下午盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452949290","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452949290?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:55","pubTimestamp":1721156151,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日02时55分，BioCryst制药股票出现异动，股价大幅拉升5.00%。截至发稿，该股报7.54美元/股，成交量125.319万股，换手率0.61%，振幅3.76%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.53%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717025551af929d07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717025551af929d07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2448913307","title":"BioCryst制药盘中异动 股价大涨5.02%报6.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913307","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448913307?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:38","pubTimestamp":1719841080,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时38分，BioCryst制药股票出现异动，股价急速拉升5.02%。截至发稿，该股报6.49美元/股，成交量19.2256万股，换手率0.09%，振幅4.85%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.44%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213800aef76d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213800aef76d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2440493259","title":"BioCryst制药盘中异动 快速上涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440493259","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440493259?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:31","pubTimestamp":1717421476,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时31分，BioCryst制药股票出现异动，股价大幅上涨5.50%。截至发稿，该股报6.82美元/股，成交量19.984万股，换手率0.10%，振幅0.15%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.35%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213117968117f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213117968117f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2439262095","title":"BioCryst制药盘中异动 股价大涨5.04%报6.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439262095","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439262095?lang=zh_cn&edition=full","pubTime":"2024-05-31 00:59","pubTimestamp":1717088395,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日00时59分，BioCryst制药股票出现波动，股价快速上涨5.04%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.19%。消息层面，截至00时59分，《BioCryst制药董事增持2,500股普通股股份，价值约1.6万美元》资讯为影响BioCryst制药的重要信息。该信息摘要如下：5月30日报道，根据美国证券交易委员会5月29日披露的文件，$BioCryst制药 $董事ASELAGE STEVE于5月24日以每股平均价6.4美元增持2,500股普通股股份，价值约为1.6万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024053100595596810dfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024053100595596810dfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2437768225","title":"BioCryst制药盘中异动 早盘急速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437768225","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437768225?lang=zh_cn&edition=full","pubTime":"2024-05-23 22:08","pubTimestamp":1716473328,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日22时08分，BioCryst制药股票出现异动，股价快速跳水5.11%。截至发稿，该股报6.32美元/股，成交量45.0766万股，换手率0.22%，振幅4.95%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.26%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523220849aef15838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523220849aef15838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2435516270","title":"BioCryst制药盘中异动 早盘股价大涨5.06%报5.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435516270","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435516270?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:32","pubTimestamp":1715693570,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时32分，BioCryst制药股票出现波动，股价急速上涨5.06%。截至发稿，该股报5.92美元/股，成交量10.8198万股，换手率0.05%，振幅3.53%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.14%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421325087e87cc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421325087e87cc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4139","BK4547"],"gpt_icon":0},{"id":"2435067583","title":"BioCryst制药盘中异动 下午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435067583","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435067583?lang=zh_cn&edition=full","pubTime":"2024-05-14 02:07","pubTimestamp":1715623679,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日02时07分，BioCryst制药股票出现波动，股价快速拉升5.08%。截至发稿，该股报5.59美元/股，成交量115.26万股，换手率0.56%，振幅4.51%。BioCryst制药股票所在的生物技术行业中，整体涨幅为1.21%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514020800792764d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514020800792764d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4547","BCRX"],"gpt_icon":0},{"id":"2434876026","title":"BioCryst制药2024财年第一财季实现净利润-35.38百万美元，同比增加33.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434876026","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434876026?lang=zh_cn&edition=full","pubTime":"2024-05-12 00:22","pubTimestamp":1715444573,"startTime":"0","endTime":"0","summary":"3月31日，BioCryst制药公布财报，公告显示公司2024财年第一财季净利润为-35.38百万美元，同比增加33.66%；其中营业收入为92.76百万美元，同比增加34.86%，每股基本收益为-0.17美元。从资产负债表来看，BioCryst制药总负债9.44亿美元，其中短期债务28.76百万美元，资产负债比为0.50，流动比率为3.73。机构评级：截至2024年3月31日，当前有11家机构对BioCryst制药目标价做出预测，其中目标均价为14.00美元，其中最低目标价为6.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120023058759664e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120023058759664e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX"],"gpt_icon":0},{"id":"2434511058","title":"BioCryst制药盘中异动 早盘股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434511058","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434511058?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:43","pubTimestamp":1715348610,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时43分，BioCryst制药股票出现异动，股价快速拉升5.24%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.16%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。该信息摘要如下：摩根大通证券公司：维持BioCryst Pharma评级，由优于大市调整至优于大市评级, 目标价由14.00美元调整至15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102143317a594117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102143317a594117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2433841037","title":"摩根大通证券公司：维持BioCryst Pharma(BCRX.US)评级，由优于大市调整至优于大市评级, 目标价由14.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433841037","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433841037?lang=zh_cn&edition=full","pubTime":"2024-05-07 23:34","pubTimestamp":1715096073,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持BioCryst Pharma(BCRX.US)评级，由优于大市调整至优于大市评级, 目标价由14.00美元调整至15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072334358ae56695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072334358ae56695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX"],"gpt_icon":0},{"id":"2433788579","title":"BioCryst制药盘中异动 早盘股价大涨5.12%报5.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433788579","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433788579?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:31","pubTimestamp":1715088680,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时31分，BioCryst制药股票出现异动，股价大幅上涨5.12%。截至发稿，该股报5.54美元/股，成交量21.1113万股，换手率0.10%，振幅2.85%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.74%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。该信息摘要如下：HC Wainwright & Co.：重申BioCryst Pharma评级，由买入调整至买入评级, 目标价30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072131217a588547&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072131217a588547&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4547","BCRX"],"gpt_icon":0},{"id":"2433727590","title":"HC Wainwright & Co.：重申BioCryst Pharma(BCRX.US)评级，由买入调整至买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433727590","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433727590?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:26","pubTimestamp":1715077570,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申BioCryst Pharma(BCRX.US)评级，由买入调整至买入评级, 目标价30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050718261287dc18cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050718261287dc18cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX"],"gpt_icon":0},{"id":"2433724078","title":"美国研究综述-ServiceNow、Ulta Beauty、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724078","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433724078?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:20","pubTimestamp":1715070052,"startTime":"0","endTime":"0","summary":"    路透5月7日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 ServiceNow、Ulta Beauty 和 Vertex Pharmaceuticals。要闻  * 艾睿电子  ：雷蒙德-詹姆斯将目标价从130美元上调至135美元 * Cardinal Health Inc   ：杰富瑞将目标价从110美元下调至105美元 * ServiceNow Inc   ：贝雅将目标价从870美元上调至885美元 * Ulta Beauty Inc   ：奥本海默将目标价从500美元下调至475美元 * Vertex Pharmaceuticals Inc   ：Piper Sandler将目标价从450美元上调至456美元 以下是路透周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","BOWL","PLTR","COTY","LYRA","BECN","ACT","FIS","VERX","CAH","ENTA","FRPT","CTO","BV","ATI","EVER","LMND","MCHP","LU0889566641.SGD","IART","BK4117","CIVI","HIMS","BK4097","BK4204","ARW","MTZ","PNW","GOSS","BCRX","GOOD","HWM","DSGN","KRC","APA","LITE","NOW","IR","VRTX","ACA","LU1064131342.USD","GLYC","CRNX","BK4567","CTRA","AIG","PACS","ACHC","LINC"],"gpt_icon":0},{"id":"2433295494","title":"BioCryst因肿胀障碍治疗产品销售强劲而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2433295494","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433295494?lang=zh_cn&edition=full","pubTime":"2024-05-06 19:26","pubTimestamp":1714994776,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月6日 - ** 制药商 BioCryst Pharmaceuticals    的股价盘前上涨 ~7.4% 至 4.78 美元* (link) * 由于遗传性血管性水肿治疗药物Orladeyo销售强劲，该公司第一季度营收为9280万美元，高于分析师平均预期的8560万美元 - LSEG数据** 遗传性血管性水肿是一种以反复发作的严重肿胀为特征的疾病。 ** 截至上次收盘，股价累计下跌 25.7","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX","BK4139","BK4547","BUZZ"],"gpt_icon":0},{"id":"2432907124","title":"BioCryst Pharmaceuticals Inc    预计每股亏损 21 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432907124","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432907124?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:47","pubTimestamp":1714751232,"startTime":"0","endTime":"0","summary":"   * BioCryst Pharmaceuticals Inc    将于5月6日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 BioCryst Pharmaceuticals Inc 的平均预期是每股亏损 21 美分。* 华尔街对 BioCryst Pharmaceuticals Inc 的 12 个月目标价中位数为 11.00 美元，高于其上次收盘价 4.48 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCRX"],"gpt_icon":0},{"id":"2432701765","title":"BioCryst制药盘中异动 早盘股价大涨5.21%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432701765","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432701765?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:37","pubTimestamp":1714570665,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时37分，BioCryst制药股票出现波动，股价大幅拉升5.21%。截至发稿，该股报4.35美元/股，成交量39.2098万股，换手率0.19%，振幅4.35%。BioCryst制药股票所在的生物技术行业中，整体涨幅为0.52%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121374587e852b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121374587e852b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BCRX","BK4139"],"gpt_icon":0},{"id":"2428660157","title":"BioCryst制药盘中异动 下午盘股价大跌5.00%报4.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428660157","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428660157?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:26","pubTimestamp":1713551180,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时26分，BioCryst制药股票出现波动，股价急速跳水5.00%。截至发稿，该股报4.28美元/股，成交量223.47万股，换手率1.08%，振幅6.78%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.04%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042002262087e822fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042002262087e822fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4547","BCRX"],"gpt_icon":0},{"id":"2427982606","title":"BUZZ-美国医疗保险公司因 UnitedHealth 第一季度利润增长而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2427982606","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427982606?lang=zh_cn&edition=full","pubTime":"2024-04-16 20:25","pubTimestamp":1713270314,"startTime":"0","endTime":"0","summary":"    4月16日 - ** 联合健康集团  公布第一季度财报后，美国医疗保险公司股价在盘前交易中上涨2%至5%。** 尽管其 Change Healthcare 部门 2 月份遭受的网络攻击造成了干扰，但 UNH 仍公布了  乐观的第一季度副利润，并维持 2024 年的业绩预期。** 竞争对手 Humana   上涨 4.6%，CVS Health   上涨 3.8%，Cigna Group   上涨 2.1** 自 11 月下旬以来，医疗保险公司的股价一直承压，当时 UNH 表示，老年人医疗保健的年末增长导致了医疗成本的上升。** 截至目前，HUM 下跌 31.3%，CVS 下跌 12.7%，UNH 下跌 15.4%，而 CI 则上涨 16.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00BJT1NW94.SGD","LU1989771016.USD","LU0122379950.USD","LU0348723411.USD","BUZZ","LU1670628061.USD","IE00B19Z9P08.USD","IE0004445239.USD","UNH","SG9999001077.SGD","IE00BFSS8Q28.SGD","BK4533","LU0957791311.USD","IE00BFTCPJ56.SGD","BCRX","BK4585","LU0320765489.SGD","BK4532","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4196","LU0353189680.USD","IE0009355771.USD","LU0208291251.USD","LU1059921491.USD","LU0251142724.SGD","IE0034235188.USD","CVS","LU0061475181.USD","LU0109391861.USD","LU0211331839.USD","LU1280957306.USD","LU0211326755.USD","LU0868494617.USD","IE00B894F039.SGD","LU1983260115.SGD","ELV","BK4534","CNC","LU0198837287.USD","LU0058720904.USD","LU0882574055.USD","LU0256863811.USD","LU0390134368.USD","LU0128525929.USD","CI","HUM","IE00B1XK9C88.USD"],"gpt_icon":0},{"id":"2426299115","title":"BioCryst制药盘中异动 下午盘大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426299115","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426299115?lang=zh_cn&edition=full","pubTime":"2024-04-12 02:31","pubTimestamp":1712860268,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日02时31分，BioCryst制药股票出现波动，股价快速拉升5.03%。BioCryst制药股票所在的生物技术行业中，整体跌幅为0.07%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科，如生物学、计算机建模和药物化学。该信息摘要如下：Needham：重申BioCryst Pharma评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120231087a5231e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120231087a5231e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0},{"id":"2426408494","title":"BioCryst制药盘中异动 快速下挫5.00%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426408494","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426408494?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:43","pubTimestamp":1712756581,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时43分，BioCryst制药股票出现异动，股价急速跳水5.00%。截至发稿，该股报4.56美元/股，成交量11.2751万股，换手率0.05%，振幅2.60%。BioCryst制药股票所在的生物技术行业中，整体跌幅为1.53%。BioCryst制药公司简介：BioCryst Pharmaceuticals Inc 是一家生物技术公司，主要从事新型小分子药物的研究和开发，以阻断感染和炎症疾病的关键酶。该信息摘要如下：Needham：重申BioCryst Pharma评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021430187e7f4c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021430187e7f4c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCRX","BK4547","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocryst.com","stockEarnings":[{"period":"1week","weight":-0.021},{"period":"1month","weight":0.1636},{"period":"3month","weight":0.7743},{"period":"6month","weight":0.3706},{"period":"1year","weight":0.0149},{"period":"ytd","weight":0.2471}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.017},{"period":"3month","weight":0.0957},{"period":"6month","weight":0.1347},{"period":"1year","weight":0.2192},{"period":"ytd","weight":0.1651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioCryst Pharmaceuticals, Inc.是一家生物技术公司，致力于设计、优化和开发新的药物，新的药物主要是阻止疾病的发病机制的关键酶。该公司是一家始建于1986年的特拉华州公司，该公司专注于治疗领域有未满足的医疗需求，并将其能力与专长联系在一起。公司的利益区域和候选药物的相关开发是由科学发现和潜在的优势，其经验丰富的药物研发组标识，以及这些发现内潜在的商业机会来决定的。该公司通过名为结构导向药物设计过程整合生物学，晶体学，药物化学和计算机模拟等学科，发现和开发小分子药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.566667,"avgChangeRate":0.030527},{"month":2,"riseRate":0.5,"avgChangeRate":-0.014169},{"month":3,"riseRate":0.366667,"avgChangeRate":0.019768},{"month":4,"riseRate":0.548387,"avgChangeRate":0.044665},{"month":5,"riseRate":0.548387,"avgChangeRate":0.05805},{"month":6,"riseRate":0.612903,"avgChangeRate":0.033442},{"month":7,"riseRate":0.580645,"avgChangeRate":0.120802},{"month":8,"riseRate":0.566667,"avgChangeRate":0.099165},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.045723},{"month":10,"riseRate":0.5,"avgChangeRate":-0.050698},{"month":11,"riseRate":0.5,"avgChangeRate":0.042837},{"month":12,"riseRate":0.466667,"avgChangeRate":0.002044}],"exchange":"NASDAQ","name":"BioCryst制药","nameEN":"Biocryst Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioCryst制药(BCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioCryst制药,BCRX,BioCryst制药股票,BioCryst制药股票老虎,BioCryst制药股票老虎国际,BioCryst制药行情,BioCryst制药股票行情,BioCryst制药股价,BioCryst制药股市,BioCryst制药股票价格,BioCryst制药股票交易,BioCryst制药股票购买,BioCryst制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioCryst制药(BCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}